Robert Markewitz

ORCID: 0000-0003-1676-1085
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • German Literature and Culture Studies
  • Peripheral Neuropathies and Disorders
  • Public Administration and Political Analysis
  • SARS-CoV-2 detection and testing
  • Medical Practices and Rehabilitation
  • Autoimmune Neurological Disorders and Treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Diabetes and associated disorders
  • Herpesvirus Infections and Treatments
  • Hematological disorders and diagnostics
  • Advanced Memory and Neural Computing
  • Health and Medical Studies
  • Platelet Disorders and Treatments
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • Long-Term Effects of COVID-19
  • Neural dynamics and brain function
  • Medical and Health Sciences Research
  • Biomedical and Chemical Research
  • Multiple and Secondary Primary Cancers
  • interferon and immune responses
  • Transcranial Magnetic Stimulation Studies
  • Infant Health and Development

University Hospital Schleswig-Holstein
2020-2025

University of Lübeck
2020-2025

Clinical Research Center Kiel
2024

Ludwig-Maximilians-Universität München
2021

Jena University Hospital
2021

Klinikum Ludwigshafen
2021

University of Regensburg
2015-2018

Joana P. Bernardes Neha Mishra Florian Tran Thomas Bahmer Lena Best and 95 more Johanna I. Blase Dora Bordoni Jeanette Franzenburg Ulf Geisen Jonathan Josephs‐Spaulding Philipp Köhler Axel Künstner Elisa Rosati Anna C. Aschenbrenner Petra Bächer Nathan Baran Teide Jens Boysen Burkhard Brandt Niklas Bruse Jonathan Dörr Andreas Dräger Gunnar Elke David Ellinghaus Julia Fischer Michael Förster André Franke Sören Franzenburg Norbert Frey Anette Friedrichs Janina Fuß Andreas Glück Jacob Hamm Finn Hinrichsen Marc P. Hoeppner Simon Imm Ralf Junker Sina Kaiser Ying H. Kan Rainer Knoll Christoph Lange Georg Laue Clemens Lier Matthias Lindner Γεώργιος Μαρίνος Robert Markewitz Jacob Nattermann Rainer Noth Peter Pickkers Klaus F. Rabe Alina Renz Christoph Röcken Jan Rupp Annika Schaffarzyk Alexander Scheffold Jonas Schulte-Schrepping Domagoj Schunk Dirk Skowasch Thomas Ulas Klaus‐Peter Wandinger Michael Wittig Johannes Zimmermann Hauke Busch Bimba F. Hoyer Christoph Kaleta Jan Heyckendorf Matthijs Kox Jan Rybniker Stefan Schreiber Joachim L. Schultze Philip Rosenstiel Nicholas E. Banovich Tushar J. Desai Oliver Eickelberg Muzlifa Haniffa Péter Horváth Jonathan A. Kropski Robert Lafyatis Joakim Lundeberg Kerstin B. Meyer Martijn C. Nawijn Marko Nikolić José Ordovas Montañes Dana Pe’er Purushothama Rao Tata Emma L. Rawlins Aviv Regev Paul A. Reyfman Christos Samakovlis Joachim L. Schultze Alex K. Shalek Douglas P. Shepherd Jason R. Spence Sarah A. Teichmann Fabian J. Theis Alexander M. Tsankov Maarten van den Berge Michael von Papen Jeffrey A. Whitsett Laure‐Emmanuelle Zaragosi Angel Angelov

10.1016/j.immuni.2020.11.017 article EN publisher-specific-oa Immunity 2020-11-26

In light of the SARS-CoV-2 pandemic, protecting vulnerable groups has become a high priority. Persons at risk severe disease, for example, those receiving immunosuppressive therapies chronic inflammatory cdiseases (CIDs), are prioritised vaccination. However, data concerning generation protective antibody titres in immunosuppressed patients scarce. Additionally, mRNA vaccines represent new vaccine technology leading to increased insecurity especially with CID.Here we present first time, on...

10.1136/annrheumdis-2021-220272 article EN cc-by-nc Annals of the Rheumatic Diseases 2021-03-24
Franziska S. Thaler Luise Zimmermann Stefan Kammermeier Christine Strippel Marius Ringelstein and 95 more Andrea Kraft Kurt‐Wolfram Sühs Jonathan Wickel Christian Geis Robert Markewitz Christian Urbanek Claudia Sommer Kathrin Doppler Loana Penner Jan Lewerenz Rosa Rößling Carsten Finke Harald Prüß Nico Melzer Klaus‐Peter Wandinger Frank Leypoldt Tania Kümpfel Michael Adelmann Luise Appeltshauser Ilya Ayzenberg Carolin Baade‐Büttner Andreas van Baalen Sebastian Baatz Bettina Balint Sebastian Bauer Annette Baumgärtner Sonka Benesch Robert L. Berger Sascha Berning Sarah Bernsen Christian G. Bien Corinna I. Bien Andreas Binder Stefan Bittner Daniel Bittner Franz Blaes Astrid Blaschek Justina Dargvainiene Andre Dik Mona Dreesmann Friedrich Ebinger Lena Edelhoff Sven Ehrlich Katharina Eisenhut Dominique Endres Marina Entscheva Jürgen Faiss Walid Fazeli Alexander Finke Dirk Fitzner Marina Flotats‐Bastardas Friedemann Paul Manuel A. Friese Marco Gallus M. M. Gebhard Christian Geis Anna Gorsler Armin Grau Oliver Grauer Catharina C. Groß Halime Gül Robert Handreka Niels Hansen Martin Häusler Joachim Havla Chung Ha-Yeun Wolfgang Heide Valentin Held Kerstin Hellwig Philip Hillebrand Frank Hoffmann Ulrich Hofstadt‐van Oy Fatme Seval Ismail Martina Jansen Max Kaufmann Christoph Kellinghaus Susanne Knake Peter Körtvélyessy Stjepana Kovac Markus Krämer Christos Krogias Christoph Lehrich Andreas Linsa Jan D. Lünemann Michael P. Malter Kristin Stefanie Melzer Til Menge Sven G. Meuth Gerd Meyer zu Hörste Constanze Mönig Marie‐Luise Mono Michael Nagel Tobias Neumann‐Haefelin Jost Obrocki Thomas Pfefferkorn

<h3>Background and Objectives</h3> To determine the real-world use of rituximab in autoimmune encephalitis (AE) to correlate treatment with long-term outcome. <h3>Methods</h3> Patients NMDA receptor (NMDAR)-AE, leucine-rich glioma-inactivated-1 (LGI1)- AE, contactin-associated protein-like-2 (CASPR2)-AE, or glutamic acid decarboxylase 65 (GAD65) disease from GErman Network for Research on AuToimmune Encephalitis who had received at least 1 dose a control cohort non–rituximab-treated patients...

10.1212/nxi.0000000000001088 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2021-10-01

Abstract SARS-CoV-2 RT-PCR is a critical and, at times, limited resource. Frequent Retesting of patients may strain testing infrastructure unduly. Recommendations that include cycle threshold (Ct) cutoffs incentivize early retesting when the Ct value reported. We aimed to investigate patterns in association with initial Ct-values. performed retrospective analysis results (including Ct-values) for from whom ≥ 2 samples were collected within 14 days, first which had be positive. calculated...

10.1038/s41598-024-52984-7 article EN cc-by Scientific Reports 2024-01-29

Heterologous vaccinations against SARS-CoV-2 with ChAdOx1 nCoV-19 and a second dose of an mRNA-based vaccine have been shown to be more immunogenic than homologous nCoV-19. In the current study, we examined kinetics antibody response three different vaccination regimens (homologous vs. + BNT162b2 or mRNA-1273) in longitudinal manner; whether there are differences latency amplitude early which markers most suitable detect these responses.We performed assays for anti-S1 IgG IgA, anti-NCP...

10.3389/fimmu.2022.811020 article EN cc-by Frontiers in Immunology 2022-01-19

Summary Coronavirus disease 2019 (COVID-19) displays high clinical variability but the parameters that determine severity are still unclear. Pre-existing T cell memory has been hypothesized as a protective mechanism conclusive evidence is lacking. Here we demonstrate all unexposed individuals harbor SARS-CoV-2-specific cells with marginal cross-reactivity to common cold corona and other unrelated viruses. They display low functional avidity broad protein target specificities their...

10.1101/2020.09.15.20188896 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-09-18

Abstract Differential diagnosis between Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) using cerebrospinal fluid (CSF) biomarkers is challenging. A recent study suggested that the addition of Aβ38 Aβ43 to a standard AD biomarker panel (Aβ40, Aβ42, t‐tau, p‐tau) improve differential diagnosis. We tested this hypothesis in an independent German cohort CAA patients controls same analytical techniques. found excellent discrimination controls, but not CAA. Adding did

10.1002/acn3.51987 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2024-01-07

Abstract Laboratory testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) consists of two pillars: detection viral RNA via rt-PCR as diagnostic gold standard in cases, and antibodies against SARS-CoV-2. However, concerning latter, questions remain about their prognostic value it is not clear whether all patients develop detectable antibodies. We examined sera from 347 Spanish COVID-19 patients, collected during peak epidemic outbreak Spain, presence IgA IgG SARS-CoV-2...

10.1038/s41598-021-83969-5 article EN cc-by Scientific Reports 2021-02-23

Abstract Objectives To better characterize occurrence and extent of anticoagulant-associated pseudothrombocytopenia (PTCP) in the daily routine a high-throughput clinical laboratory order to draw conclusions on more precise definition this phenomenon. Methods Concomitant platelet counts both EDTA citrate whole blood (WB) performed our over period four years 9 months, were analyzed, calculating correlation, as well absolute difference results obtained from materials, cross-referencing these...

10.1515/labmed-2023-0032 article EN cc-by Journal of Laboratory Medicine 2023-05-18

Paired associative stimulation (PAS), a form of non-invasive cortical pairing transcranial magnetic (TMS) with peripheral sensory stimulus, has been shown to induce neuroplastic effects in the human motor, somatosensory and auditory cortex. The current study investigated acoustic PAS on late evoked potentials (LAEP) influence tone duration placebo stimulation. In two experiments, 18 participants underwent 4 kHz paired 400 ms using 200 pairs stimuli (TMS-pulse over left cortex 45 after...

10.1007/s10548-018-00695-4 article EN cc-by Brain Topography 2018-12-24

Abstract The pandemic spread of the potentially life-threatening disease COVID-19 requires a thorough understanding longitudinal dynamics host responses. Temporal resolution cellular features associated with severe trajectory will be pre-requisite for finding outcome predictors. Here, we performed multi-omics study using two-centre German cohort 13 patients (from Cologne and Kiel, 1). We analysed bulk transcriptome, DNA methylome, single-cell transcriptome (&gt;358,000 cells, including BCR...

10.1101/2020.09.11.20187369 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-18

•Antibodies against SARS-CoV-2 were associated with lower viral loads of SARS-CoV-2•Higher on admission a fatal outcome•Cycle threshold values different assays and target genes not readily comparable ObjectivesTo examine the relationship between antibody status cycle (Ct) values, prognostic value latter for COVID-19 patients, inter-assay comparability Ct values.MethodsIn 347 inpatients, (via reverse transcription-quantitative polymerase chain reaction) compared 2 correlated response (in...

10.1016/j.ijid.2021.07.014 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-07-14

Ziel/Aim Ziel dieser Arbeit ist es, den Einfluss des Folsäurespiegels im Rahmen der PSMA-PET/CT-Bildgebung bei Patienten mit Prostatakarzinomen zu untersuchen. Da die physiologische enzymatische Aktivität PSMA in vitro durch Zugabe von Folsäure gehemmt werden kann und zur Bildgebung verwendeten PSMA-Liganden ebenfalls an das aktive Zentrum dieses Enzyms binden, könnte sich infolge einer kompetitiven Hemmung eine Konsequenz für ergeben.

10.1055/s-0043-1766374 article DE Nuklearmedizin - NuclearMedicine 2023-03-30
Coming Soon ...